Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Jones

Showing results (381-390 of 437) with videos related to

Pageof 44
Sort By:
Seizure|July 25, 2024
Two-year mortality and seizure recurrence following status epilepticus in Auckland, New Zealand: A prospective cohort studyTony Zhang, Adi Wa'ie Hj Ajamain, Joseph Donnelly, et al.
Emergency Medicine Australasia : EMA|July 31, 2024
Making the most of what we have: What does the future hold for Emergency Department data?Simon Craig, Gerard M O'Reilly, Diana Egerton-Warburton, et al.
BMJ (Clinical Research Ed.)|March 3, 2021
High flow oxygen and risk of mortality in patients with a suspected acute coronary syndrome: pragmatic, cluster randomised, crossover trialRalph A H Stewart, Peter Jones, Bridget Dicker, et al.
European Heart Journal|March 19, 2014
The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trialKausik K Ray, Marc Ditmarsch, David Kallend, et al.
ACS Medicinal Chemistry Letters|November 20, 2024
Cyclic Peptide C5aR1 Antagonist Design Using Solution Conformational Analysis Derived from Residual Dipolar CouplingsKathleen A Farley, Ye Che, Ricardo Lira, et al.
International Journal of Cancer|February 5, 2024
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patientsValerie Lee, Rose Parkinson, Marianna Zahurak, et al.
Paediatric and Perinatal Epidemiology|May 6, 2021
Risk factors for very preterm delivery out of a level III maternity unit: The EPIPAGE-2 cohort studyThomas Desplanches, Andrei S Morgan, Peter Jones, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
DNA binding ligands with in vivo efficacy in murine models of bacterial infection: optimization of internal aromatic amino acidsRoland W Bürli, Jacob A Kaizerman, Jian-Xin Duan, et al.
Journal of Infection and Public Health|September 22, 2023
Do mobile phone surfaces carry SARS-CoV-2 virus? A systematic review warranting the inclusion of a "6th" moment of hand hygiene in healthcareMatthew Olsen, Thibaut Demaneuf, Gobinddeep Singh, et al.
The Journal of Infection|February 21, 2023
National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school childrenAnnabel A Powell, Georgina Ireland, Rebecca Leeson, et al.
Pageof 44

Showing results (381-390 of 437) with videos related to

Sort By:
Pageof 44
Seizure|July 25, 2024
Two-year mortality and seizure recurrence following status epilepticus in Auckland, New Zealand: A prospective cohort studyTony Zhang, Adi Wa'ie Hj Ajamain, Joseph Donnelly, et al.
Emergency Medicine Australasia : EMA|July 31, 2024
Making the most of what we have: What does the future hold for Emergency Department data?Simon Craig, Gerard M O'Reilly, Diana Egerton-Warburton, et al.
BMJ (Clinical Research Ed.)|March 3, 2021
High flow oxygen and risk of mortality in patients with a suspected acute coronary syndrome: pragmatic, cluster randomised, crossover trialRalph A H Stewart, Peter Jones, Bridget Dicker, et al.
European Heart Journal|March 19, 2014
The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trialKausik K Ray, Marc Ditmarsch, David Kallend, et al.
ACS Medicinal Chemistry Letters|November 20, 2024
Cyclic Peptide C5aR1 Antagonist Design Using Solution Conformational Analysis Derived from Residual Dipolar CouplingsKathleen A Farley, Ye Che, Ricardo Lira, et al.
International Journal of Cancer|February 5, 2024
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patientsValerie Lee, Rose Parkinson, Marianna Zahurak, et al.
Paediatric and Perinatal Epidemiology|May 6, 2021
Risk factors for very preterm delivery out of a level III maternity unit: The EPIPAGE-2 cohort studyThomas Desplanches, Andrei S Morgan, Peter Jones, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
DNA binding ligands with in vivo efficacy in murine models of bacterial infection: optimization of internal aromatic amino acidsRoland W Bürli, Jacob A Kaizerman, Jian-Xin Duan, et al.
Journal of Infection and Public Health|September 22, 2023
Do mobile phone surfaces carry SARS-CoV-2 virus? A systematic review warranting the inclusion of a "6th" moment of hand hygiene in healthcareMatthew Olsen, Thibaut Demaneuf, Gobinddeep Singh, et al.
The Journal of Infection|February 21, 2023
National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school childrenAnnabel A Powell, Georgina Ireland, Rebecca Leeson, et al.
Pageof 44